OpenURL Connection Search

Select item for more details and to access through your institution.

Comment faire progresser les connaissances sur la toxicité des immunothérapies en 2024 ?
Published in:
Revue Immunité & Cancer, 2023, v. 7, n. 4, p. 159
By:
- POURMIR, Ivan;
- NEBBACHE, Rafik.;
- ESLAMI, Assié;
- CHAMPIAT, Stéphane;
- DRAGON-DUREY, Marie-Agnès;
- WEISS, Laurence;
- MIRABEL, Mariana;
- FABRE, Elizabeth;
- OUDARD, Stéphane;
- VANO, Yann-Alexandre;
- MEDIONI, Jacques;
- SIBERIL, Sophie;
- LE BELLER, Christine;
- WALLET, Jennifer;
- DONIA, Marco;
- TRAPANI, Dario;
- VAN HALTEREN, Hendrik K.;
- CLARKE, Mike;
- LAMBOTTE, Olivier
Publication type:
Article
CXCR6 expressing T cells: Functions and role in the control of tumors.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1022136
By:
- Mabrouk, Nesrine;
- Thi Tran;
- Sam, Ikuan;
- Pourmir, Ivan;
- Gruel, Nadège;
- Granier, Clèmence;
- Pineau, Josèphine;
- Gey, Alain;
- Kobold, Sebastian;
- Fabre, Elizabeth;
- Tartour, Eric
Publication type:
Article
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma.
Published in:
World Journal of Urology, 2021, v. 39, n. 5, p. 1377, doi. 10.1007/s00345-020-03528-x
By:
- Pourmir, Ivan;
- Noel, Johanna;
- Simonaggio, Audrey;
- Oudard, Stéphane;
- Vano, Yann-Alexandre
Publication type:
Article
Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression.
Published in:
Cancers, 2023, v. 15, n. 23, p. 5587, doi. 10.3390/cancers15235587
By:
- Pourmir, Ivan;
- Elaidi, Reza;
- Maaradji, Zineb;
- De Saint Basile, Hortense;
- Ung, Monivann;
- Ismaili, Mohammed;
- Fournier, Laure;
- Rance, Bastien;
- Gibault, Laure;
- Ben Dhiab, Rym;
- Gazeau, Benoit;
- Fabre, Elizabeth
Publication type:
Article

Found: 4

Comment faire progresser les connaissances sur la toxicité des immunothérapies en 2024 ?

CXCR6 expressing T cells: Functions and role in the control of tumors.

Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma.

Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression.